Residential Electromagnetic Fields Not An Apparent Threat to Human Health

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 12
Volume 5
Issue 12

WASHINGTON--Exposure to residential electric and magnetic fields (EMFs) appears to pose no serious threat to human health, according to a National Research Council (NRC) committee. The panel reviewed more than 500 studies conducted in the 17 years since researchers reported that children living near high-voltage power lines were 1.5 times more likely to develop leukemia.

WASHINGTON--Exposure to residential electric and magnetic fields(EMFs) appears to pose no serious threat to human health, accordingto a National Research Council (NRC) committee. The panel reviewedmore than 500 studies conducted in the 17 years since researchersreported that children living near high-voltage power lines were1.5 times more likely to develop leukemia.

"Research has not shown in any convincing way that EMFs commonin homes can cause health problems, and extensive laboratory testshave not shown that EMFs can damage the cell in a way that isharmful to human health," said Charles F. Stevens, MD, PhD,of the Howard Hughes Medical Institute and the Salk Institute,who chaired the committee.

In the NRC review, no conclusive evidence emerged to link EMFsfound in homes to cancer, reproductive and development abnormalities,or learning and behavioral problems.

The NRC committee did, however, find a weak but nonetheless significantcorrelation between the incidence of childhood leukemia and proximityof large power lines. This link may result from factors otherthan EMFs, the panel said, including heavy traffic near powerlines, other types of local air pollution, and construction inolder homes that allows more pollutants to enter.

Recent Videos
The approval of daratumumab validates the notion of using limited therapy to help delay progression from smoldering disease to multiple myeloma.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
A simulation procedure helped to ascertain chemotherapy tolerability before administering radioembolization therapy for NETs with liver metastases.
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
Related Content